Limfoma
The lymph in the human body is actually complicated. Lymphoma is the fastest and the highest death in malignant tumors, because the lymphatic system of the human body has a great effect on the whole body. Once cancer cells appear, they will spread along the blood , It will be spread all over the body, which makes the treatment more difficult. Lymphoma targeted drugs are not completely free of side effects. The patients who use them must carefully observe their changes bit by bit and communicate with the doctor in time to be able to reduce.
Vai limfomas zāles ir efektīvas?
Early malignant lymphoma is actually lymphoma. When using targeted drugs, you must first perform genetic testing on the patient. When you find the corresponding targeted drugs, the targeted drugs have a direct killing effect on cancer cells. The advantage is that the damage to normal cells is not too great. Although there are side effects and drug resistance, it depends on the patient’s physical function, good physical fitness, high immunity, and the best therapeutic effect. Therefore, patients with lymphoma have to find ways to improve their immune function and enhance their resistance to tumors while using targeted drugs.
Targeted drug therapy affects the biological processes of cells, acting in different ways, preventing cancer cells from growing or dividing, causing cancer cells to die or using their own immune system to help the body kill cancer cells. Compared with chemotherapy, targeted drugs can act more precisely on lymphoma cells and reduce the impact of treatment on healthy cells, thereby reducing the side effects of treatment while being more effective.
Kādas ir limfomas mērķa zāles?
Rituximab is the first targeted immunotherapy drug used to treat lymphoma. There are many other targeted drugs for the treatment of patients with lymphoma, some have been approved for marketing, and many drugs are still in clinical trials.
1. Hroniska limfocītiskā leikēmija (HLL) / mazā limfoleikoze (SLL)
• Ibrutinibs (Ibutinibs, Imbruvica Eke)
• Idelalisibs (Edelalis, Zydelig)
• Obinutuzumabs (Atoruzumabs, Gaziva)
• rituksimabs (rituksimabs, rituksāna merova);
2. Ādas (ādas) T šūnu limfoma
• Brentuksimaba vedotīns (Bentuksimabs, Adcetris)
3. Difūzā lielo B šūnu limfoma
• rituksimabs (rituksimabs, rituksāna merova);
4. Folikulāra limfoma
• Idelalisibs (Edelalis, Zydelig)
• Obinutuzumabs (Atoruzumabs, Gaziva)
• rituksimabs (rituksimabs, rituksāna merova);
• Ibritumomaba tiuksetāns (Timobizumabs, Zevalins)
5. Klasiskā Hodžkina limfoma
• Brentuksimaba vedotīns (Bentuksimabs, Adcetris)
• Nivolumabs (Navuliu monoklonālā antiviela, Opdivo)
• Pembrolizumab (Pambrolizumab, Keytruda)
6. Primārā videnes B-šūnu limfoma
• rituksimabs (rituksimabs, rituksāna merova);
7. Manteles šūnu limfoma
• Bortezomibs (bortezomibs, Velcade Velcade)
• Ibrutinibs (Ibutinibs, Imbruvica Eke)
• Lenalidomīds (Lenalidomīds, Revlimid)
• Temsirolimus (sirolimus, Torisel)
8. Sistēmiska anaplastiska lielšūnu limfoma
• Brentuksimaba vedotīns (Bentuksimabs, Adcetris)
Nav standarta skaitļa par limfomas mērķa zāļu cenu
Uz limfomu vērstas zāles galvenokārt ir rituksimabs (rituksimaba injekcija), ārstēšanas kurss ir aptuveni 10,000 20,000 vai XNUMX XNUMX. Īpašais ir atkarīgs no paša pacienta situācijas. Ja nav zāļu izturības, varat turpināt to lietot. Ja ir blakusparādības vai zāļu izturība, jums jāaptur vai jāizmanto citas ārstēšanas metodes. Tāpēc cena nav noteikta. Būs izmaiņas.
Tīras asinis organismā pārvalda asinsrades sistēma, un limfātiskā sistēma ir vadītājs. Pašlaik ir daudz elektronisko izstrādājumu, un radiācija ir visur, un ir vīrusu infekcijas, kas parādās jebkurā laikā. Tie ir nāvējoši limfomas stimuli, jums jāpievērš lielāka uzmanība tam, lai dzīvē izvairītos no limfomas, un mērķtiecīgu limfomu izraisošu zāļu izvēle nav tik nejauša.
